These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18695170)

  • 41. Correct use of proton pump inhibitors for gastro-oesophageal reflux disease.
    Hatlebakk JG; Emken BE; Glazkov V; Hoff DA; Hausken T
    Tidsskr Nor Laegeforen; 2013 Jan; 133(1):43-6. PubMed ID: 23306993
    [No Abstract]   [Full Text] [Related]  

  • 42. Long-term use of PPIs in children: we have questions.
    Hassall E; Owen D
    Dig Dis Sci; 2008 Apr; 53(4):1158-60, author reply 1161-2. PubMed ID: 18259863
    [No Abstract]   [Full Text] [Related]  

  • 43. Letter by Montenegro and Lundberg regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".
    Montenegro MF; Lundberg JO
    Circulation; 2014 Apr; 129(13):e426. PubMed ID: 24687652
    [No Abstract]   [Full Text] [Related]  

  • 44. [Long-term use of proton pump inhibitors--really harmless?].
    Haag S
    Dtsch Med Wochenschr; 2013 Nov; 138(45):2319-21. PubMed ID: 24163169
    [No Abstract]   [Full Text] [Related]  

  • 45. Biological plausibility between proton pump inhibitory therapy and hip fracture: hyperhomocysteinemia can be the link.
    Roblin X; Phelip JM
    Am J Gastroenterol; 2009 Apr; 104(4):1052. PubMed ID: 19240711
    [No Abstract]   [Full Text] [Related]  

  • 46. Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".
    Ghebremariam YT; Lee JC; LePendu P; Erlanson DA; Slaviero A; Shah NH; Leiper JM; Cooke JP
    Circulation; 2014 Apr; 129(13):e428. PubMed ID: 24687654
    [No Abstract]   [Full Text] [Related]  

  • 47. [Gastroesophageal reflux disease: pathogenetic basis of differentiated tactics of treatment].
    Tkachenko EI; Uspenskiĭ IuP; Karateev AE; Bakulin IG; Pakhomova IG
    Eksp Klin Gastroenterol; 2009; (2):104-14. PubMed ID: 19552028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Letter by Pinheiro et al regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".
    Pinheiro LC; Amaral JH; Tanus-Santos JE
    Circulation; 2014 Apr; 129(13):e427. PubMed ID: 24687653
    [No Abstract]   [Full Text] [Related]  

  • 49. Letter by Chyrchel et al regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".
    Chyrchel B; Chyrchel M; Surdacki A
    Circulation; 2014 Apr; 129(13):e425. PubMed ID: 24687651
    [No Abstract]   [Full Text] [Related]  

  • 50. Proton pump inhibitors and fractures? Beware long-term use.
    Prescrire Int; 2009 Oct; 18(103):216. PubMed ID: 19885973
    [No Abstract]   [Full Text] [Related]  

  • 51. Infants and proton pump inhibitors: tribulations, no trials.
    Orenstein SR; Hassall E
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):395-8. PubMed ID: 18030202
    [No Abstract]   [Full Text] [Related]  

  • 52. The relationship among proton pump inhibitors, bone disease and fracture.
    Targownik LE; Leslie WD
    Expert Opin Drug Saf; 2011 Nov; 10(6):901-12. PubMed ID: 21599546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proton Pump Inhibitor Use and Outcomes in Children With Respiratory Symptoms.
    Rosen R; Rahbar R
    JAMA Otolaryngol Head Neck Surg; 2018 Jul; 144(7):555-556. PubMed ID: 29800938
    [No Abstract]   [Full Text] [Related]  

  • 54. [Gastroesophageal reflux and proton pump inhibitors: panacea or prescription abuse?].
    Mouterde O; Bellaïche M; Dumant C; Mallet E
    Arch Pediatr; 2010 Jun; 17(6):739-40. PubMed ID: 20654868
    [No Abstract]   [Full Text] [Related]  

  • 55. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proton Pump Inhibitors: The Good, Bad, and Ugly.
    Schnoll-Sussman F; Niec R; Katz PO
    Gastrointest Endosc Clin N Am; 2020 Apr; 30(2):239-251. PubMed ID: 32146944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children.
    Lee JH; Kim MJ; Lee JS; Choe YH
    Arch Dis Child; 2011 Jan; 96(1):9-13. PubMed ID: 20870626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of GERD and proton pump inhibitor use in the elderly: practical approaches and frequently asked questions.
    Scholl S; Dellon ES; Shaheen NJ
    Am J Gastroenterol; 2011 Mar; 106(3):386-92. PubMed ID: 21378759
    [No Abstract]   [Full Text] [Related]  

  • 59. Proton pump inhibitors: Adverse effects.
    Sataloff RT
    Ear Nose Throat J; 2010 Dec; 89(12):574-6. PubMed ID: 21174271
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.
    Tjon JA; Pe M; Soscia J; Mahant S
    Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.